The Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Center for Molecular Medicine and Genomics, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Genes (Basel). 2020 Sep 30;11(10):1162. doi: 10.3390/genes11101162.
When discussing chromosomal instability, most of the literature focuses on the characterization of individual molecular mechanisms. These studies search for genomic and environmental causes and consequences of chromosomal instability in cancer, aiming to identify key triggering factors useful to control chromosomal instability and apply this knowledge in the clinic. Since cancer is a phenomenon of new system emergence from normal tissue driven by somatic evolution, such studies should be done in the context of new genome system emergence during evolution. In this perspective, both the origin and key outcome of chromosomal instability are examined using the genome theory of cancer evolution. Specifically, chromosomal instability was linked to a spectrum of genomic and non-genomic variants, from epigenetic alterations to drastic genome chaos. These highly diverse factors were then unified by the evolutionary mechanism of cancer. Following identification of the hidden link between cellular adaptation (positive and essential) and its trade-off (unavoidable and negative) of chromosomal instability, why chromosomal instability is the main player in the macro-cellular evolution of cancer is briefly discussed. Finally, new research directions are suggested, including searching for a common mechanism of evolutionary phase transition, establishing chromosomal instability as an evolutionary biomarker, validating the new two-phase evolutionary model of cancer, and applying such a model to improve clinical outcomes and to understand the genome-defined mechanism of organismal evolution.
当讨论染色体不稳定性时,大多数文献都集中于描述个体分子机制。这些研究旨在寻找癌症中染色体不稳定性的基因组和环境原因和后果,旨在识别关键的触发因素,以控制染色体不稳定性,并将这一知识应用于临床。由于癌症是一种由体细胞进化驱动的从正常组织中出现的新系统现象,因此此类研究应该在进化过程中新基因组系统出现的背景下进行。从这个角度来看,染色体不稳定性的起源和关键结果都可以使用癌症进化的基因组理论来检验。具体来说,染色体不稳定性与一系列基因组和非基因组变异有关,从表观遗传改变到剧烈的基因组混乱。这些高度多样化的因素随后被癌症的进化机制统一起来。在确定了细胞适应性(积极和必要)与其染色体不稳定性的权衡(不可避免和消极)之间的隐藏联系之后,简要讨论了为什么染色体不稳定性是癌症宏观细胞进化的主要参与者。最后,提出了新的研究方向,包括寻找进化相变的共同机制,将染色体不稳定性确立为进化生物标志物,验证癌症的新两阶段进化模型,并将该模型应用于改善临床结果和理解生物进化的基因组定义机制。